HC Wainwright & Co. Reiterates Buy on Greenwich LifeSciences, Maintains $36 Price Target
BenzingaFeb 28 13:23 ET
Expanding Horizons: Bullish Buy Rating as Greenwich LifeSciences's Breast Cancer Trial Goes Pan-European
TipRanksFeb 28 06:27 ET
HC Wainwright & Co. Maintains Buy on Greenwich LifeSciences, Lowers Price Target to $36
BenzingaFeb 20 07:47 ET
Greenwich LifeSciences Analyst Ratings
BenzingaFeb 20 07:46 ET
Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), BioMarin Pharmaceutical (BMRN) and Greenwich LifeSciences (GLSI)
TipRanksFeb 20 06:30 ET
HC Wainwright & Co. Reiterates Buy on Greenwich LifeSciences, Lowers Price Target to $38
BenzingaApr 10, 2023 12:10 ET
H.C. Wainwright Sticks to Its Buy Rating for Greenwich LifeSciences (GLSI)
TipRanksApr 10, 2023 12:07 ET
Analysts Conflicted on These Healthcare Names: Nabriva (NBRV), Vir Biotechnology (VIR) and Greenwich LifeSciences (GLSI)
TipRanksNov 29, 2022 07:35 ET
Analysts Offer Insights on Healthcare Companies: Evofem Biosciences (OtherEVFM), Greenwich LifeSciences (GLSI) and Chinook Therapeutics (KDNY)
TipRanksAug 15, 2022 07:00 ET
No Data
No Data